InsiderTrades.com logo
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
From Priority Gold   |   Ad
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Click here for your free guide

PEAR Insider Trading

Insider Ownership Percentage: 30.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Pear Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Pear Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pear Therapeutics Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for PEAR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
From Priority Gold   |   Ad
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Click here for your free guide

Pear Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/10/20235Am Partners Iv, LlcMajor ShareholderSell16,544,113$0.12$1,985,293.56View SEC Filing Icon  
1/20/2023Christopherd T GuiffreCFOSell19,540$1.13$22,080.2029,960View SEC Filing Icon  
1/20/2023Corey MccannCEOSell34,731$1.13$39,246.038,210,834View SEC Filing Icon  
1/20/2023Ellen SnowCAOSell8,027$1.13$9,070.5123,318View SEC Filing Icon  
1/20/2023Ronan O'brienInsiderSell12,162$1.13$13,743.0618,638View SEC Filing Icon  
11/14/20225Am Partners Iv, LlcMajor ShareholderSell12,128$2.79$33,837.12537,406View SEC Filing Icon  
11/11/20225Am Partners Iv, LlcMajor ShareholderSell29,380$3.19$93,722.20537,891View SEC Filing Icon  
11/2/20225Am Partners Iv, LlcMajor ShareholderSell10,578$2.72$28,772.16539,066View SEC Filing Icon  
10/31/20225Am Partners Iv, LlcMajor ShareholderSell42,164$2.78$117,215.92539,548View SEC Filing Icon  
9/16/20225Am Partners Iv, LlcMajor ShareholderSell351$1.75$614.25541,235View SEC Filing Icon  
9/14/20225Am Partners Iv, LlcMajor ShareholderSell285,067$1.94$553,029.98552,159View SEC Filing Icon  
9/8/20225Am Partners Iv, LlcMajor ShareholderSell304,322$1.81$550,822.82563,562View SEC Filing Icon  
9/6/20225Am Partners Iv, LlcMajor ShareholderSell311,160$2.36$734,337.60581,916View SEC Filing Icon  
8/18/20225Am Partners Iv, LlcMajor ShareholderSell222,761$1.55$345,279.55594,362View SEC Filing Icon  
8/16/20225Am Partners Iv, LlcMajor ShareholderSell167,162$1.78$297,548.36603,675View SEC Filing Icon  
See Full Table
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
From Priority Gold   |   Ad
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Click here for your free guide

SEC Filings (Institutional Ownership Changes) for Pear Therapeutics (NASDAQ:PEAR)

71.17% of Pear Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PEAR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Pear Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/2/2023Arboretum Ventures LLC10,859,050$2.77M8.2%N/A7.608%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC41,941$49K0.0%N/A0.030%Search for SEC Filing on Google Icon
2/13/2023The Manufacturers Life Insurance Company29,233$34K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC25,676$30K0.0%+61.1%0.018%Search for SEC Filing on Google Icon
1/24/2023Darrow Company Inc.154,711$0.18M0.2%-15.1%0.110%Search for SEC Filing on Google Icon
11/15/2022Verdence Capital Advisors LLC13,815$28K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund48,590$99K0.0%N/A0.035%Search for SEC Filing on Google Icon
11/3/2022Darrow Company Inc.182,211$0.37M0.4%N/A0.131%Search for SEC Filing on Google Icon
11/2/2022Daiwa Securities Group Inc.12,737$26K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/31/2022SG Americas Securities LLC15,935$33K0.0%N/A0.011%Search for SEC Filing on Google Icon
10/27/2022US Bancorp DE54,897$0.11M0.0%N/A0.040%Search for SEC Filing on Google Icon
10/27/2022Strs Ohio15,900$32K0.0%N/A0.011%Search for SEC Filing on Google Icon
10/12/2022Acropolis Investment Management LLC164,842$0.34M0.0%N/A0.119%Search for SEC Filing on Google Icon
5/12/2022Magnus Financial Group LLC11,800$60K0.0%N/A0.009%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP28,900$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
4/26/2022Sciencast Management LP36,621$0.19M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/25/2022EDBI Pte Ltd426,371$2.64M1.4%N/A1.236%Search for SEC Filing on Google Icon
2/14/2022Sarissa Capital Management LP500,356$3.10M0.3%N/A1.450%Search for SEC Filing on Google Icon
2/14/2022SB Global Advisers Ltd12,100,078$75.02M1.5%N/A35.073%Search for SEC Filing on Google Icon
2/9/2022Arboretum Ventures Inc.10,859,050$67.33M38.8%N/A31.476%Search for SEC Filing on Google Icon
2/7/2022Roble Belko & Company Inc4,502$28K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/3/20225AM Venture Management LLC18,631,771$115.52M21.7%N/A54.005%Search for SEC Filing on Google Icon
1/28/2022BerganKDV Wealth Management LLC4,500$28K0.0%N/A0.013%Search for SEC Filing on Google Icon
1/18/2022TB Alternative Assets Ltd.2,071,865$12.85M3.8%N/A25.233%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Pear Therapeutics logo
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
Read More on Pear Therapeutics

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

7,748,841 shs

Market Capitalization

$4.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.45

Who are the company insiders with the largest holdings of Pear Therapeutics?

Pear Therapeutics' top insider shareholders include:
  1. Corey Mccann (CEO)
  2. 5Am Partners Iv, Llc (Major Shareholder)
  3. Christopherd T Guiffre (CFO)
  4. Ellen Snow (CAO)
  5. Ronan O'brien (Insider)
Learn More about top insider investors at Pear Therapeutics.
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
From Priority Gold   |   Ad
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Click here for your free guide